CRMD Alan W Dunton sells $131K worth of shares
Sep 17, 2025, 4:35 AM
0.00%
What does CRMD do
CorMedix is a pharmaceutical company based in New Jersey, focused on developing therapeutic products, notably DefenCath, an antimicrobial solution for preventing catheter-related bloodstream infections in kidney failure patients. The company went public in 2010 and has also sponsored research on taurolidine for rare pediatric tumors.
Alan W Dunton sold 10,000 shares of CRMD on 12 September at $13.13 per share, worth a total of $131K. They now own 40,250 CRMD shares, or a 20% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.